The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 180, 7338 -7348
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krockenberger, M.
Right arrow Articles by Wischhusen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krockenberger, M.
Right arrow Articles by Wischhusen, J.

Macrophage Migration Inhibitory Factor Contributes to the Immune Escape of Ovarian Cancer by Down-Regulating NKG2D1

Mathias Krockenberger*,{dagger}, Yvonne Dombrowski*,{dagger}, Claudia Weidler*,{dagger}, Monika Ossadnik*,{dagger}, Arnd Hönig*,{dagger}, Sebastian Häusler*, Heike Voigt{ddagger}, Jürgen C. Becker{ddagger}, Lin Leng, Alexander Steinle§, Michael Weller#, Richard Bucala,||, Johannes Dietl* and Jörg Wischhusen2,*,{dagger}

* Department for Obstetrics and Gynecology, {dagger} Interdisciplinary Center for Clinical Research, and {ddagger} Clinical research group KFO 124, University of Würzburg, Würzburg, Germany; § Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany; Department of Medicine and || Department of Pathology, Yale University School of Medicine, New Haven, CT 06520; and # Department of Neurology, University Hospital Zurich, Zurich, Switzerland

The proinflammatory cytokine macrophage migration inhibitory factor (MIF) stimulates tumor cell proliferation, migration, and metastasis; promotes tumor angiogenesis; suppresses p53-mediated apoptosis; and inhibits antitumor immunity by largely unknown mechanisms. We here describe an overexpression of MIF in ovarian cancer that correlates with malignancy and the presence of ascites. Functionally, we find that MIF may contribute to the immune escape of ovarian carcinoma by transcriptionally down-regulating NKG2D in vitro and in vivo which impairs NK cell cytotoxicity toward tumor cells. Together with the additional tumorigenic properties of MIF, this finding provides a rationale for novel small-molecule inhibitors of MIF to be used for the treatment of MIF-secreting cancers.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the Interdisciplinary Center for Clinical Research Würzburg (to J.W.) and the National Institutes of Health (to L.L. and R.B.).

2 Address correspondence and reprint requests to Dr. Jörg Wischhusen, Interdisciplinary Center for Clinical Research Junior Research Group "Tumor Progression and Immune Escape," Department of Gynecology, University of Würzburg, Josef-Schneider-Strasse 4, D-97080 Würzburg, Germany. E-mail address: Wischhusen_J{at}klinik.uni-wuerzburg.de

3 Abbreviations used in this paper: OvCA, ovarian carcinoma; MIF, macrophage migration inhibitory factor; NKG2D, natural killer group 2D; SFI, specific fluorescence intensity; SN, supernatant; rh, recombinant human.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Carlsten, H. Norell, Y. T. Bryceson, I. Poschke, K. Schedvins, H.-G. Ljunggren, R. Kiessling, and K.-J. Malmberg
Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
J. Immunol., October 15, 2009; 183(8): 4921 - 4930.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Reim, Y. Dombrowski, C. Ritter, M. Buttmann, S. Hausler, M. Ossadnik, M. Krockenberger, D. Beier, C. P. Beier, J. Dietl, et al.
Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells
Cancer Res., October 15, 2009; 69(20): 8058 - 8066.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. Prieto-Lafuente, W. F. Gregory, J. E. Allen, and R. M. Maizels
MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages
J. Leukoc. Biol., May 1, 2009; 85(5): 844 - 854.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.